Ruja Impex Profile
Key Indicators
- Authorised Capital ₹ 1.05 M
as on 14-12-2024
- Paid Up Capital ₹ 0.20 M
as on 14-12-2024
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 9.90 Cr
as on 14-12-2024
- Satisfied Charges ₹ 7.25 Cr
as on 14-12-2024
- Revenue -16.88%
(FY 2022)
- Profit 75.01%
(FY 2022)
- Ebitda 315.25%
(FY 2022)
- Net Worth 33.92%
(FY 2022)
- Total Assets 56.78%
(FY 2022)
About Ruja Impex
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.05 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹9.90 Cr. The company has closed loans amounting to ₹7.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hasmukhbhai Patel and Dasharathbhai Patel serve as directors at the Company.
- CIN/LLPIN
U51909GJ2012PTC073181
- Company No.
073181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ruja Impex Private Limited offer?
Ruja Impex Private Limited offers a wide range of products and services, including Common Disease Medicines, Skin Ointment, Ointment, Pharma Ingredients & Raw Materials, Hormones and Steroid API, Anti Inflammatory Drugs, Methylprednisolone Injection, API (Active Pharmaceutical Ingredients), Nandrolone Powder, Anti Inflammatory and Immunosuppressant API.
Who are the key members and board of directors at Ruja Impex?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hasmukhbhai Patel | Director | 28-Mar-2022 | Current |
Dasharathbhai Patel | Additional Director | 30-May-2023 | Current |
Financial Performance of Ruja Impex.
Ruja Impex Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.88% decrease. The company also saw a substantial improvement in profitability, with a 75.01% increase in profit. The company's net worth Soared by an impressive increase of 33.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ruja Impex?
In 2022, Ruja Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 04 May 2020 | ₹9.00 M | Open |
Others Creation Date: 13 Feb 2014 | ₹9.00 Cr | Open |
Others Creation Date: 11 Feb 2014 | ₹7.25 Cr | Satisfied |
How Many Employees Work at Ruja Impex?
Unlock and access historical data on people associated with Ruja Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ruja Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruja Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.